비교리스트

 카트 문의
시장보고서
상품코드
1650737

세계의 RNA 분석(전사체학) 시장

RNA Analysis / Transcriptomics
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 504 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 RNA 분석(전사체학) 시장은 2030년까지 190억 달러에 달할 전망

2024년 미화 89억 달러로 추정되는 RNA 분석(전사체학) 세계 시장은 2024-2030년 분석 기간 동안 13.4%의 연평균 성장률로 성장하여 2030년에는 미화 190억 달러에 달할 것으로 예상됩니다. 보고서에서 분석 된 유형 중 하나 인 RNA 분석(전사체학) 시약 및 소모품은 14.5 %의 CAGR을 기록하고 분석 기간이 끝날 때까지 미화 97 억 달러에이를 것으로 예상됩니다. RNA 분석(전사체학) 기기 부문의 성장은 분석 기간 동안 11.9 % CAGR로 추정됩니다.

미국 시장은 33억 달러, 중국은 CAGR 14.4%로 성장 예측

미국의 RNA 분석(전사체학) 시장은 2024년 미화 33억 달러로 추정됩니다. 세계에서 두 번째로 큰 경제 규모를 자랑하는 중국은 2024-2030년 분석 기간 동안 14.4%의 연평균 성장률을 기록하며 2030년까지 16억 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 11.5%와 13.3%의 연평균 성장률을 기록할 것으로 예상됩니다. 유럽 내에서는 독일이 약 13.2%의 연평균 성장률을 보일 것으로 예상됩니다.

세계의 RNA 분석 전사체학 시장 - 주요 동향과 촉진요인 요약

전사체학이라고도 하는 RNA 분석은 세포 또는 유기체 내의 RNA 분자에 대한 연구에 초점을 맞춘 분자 생물학에서 강력하고 필수적인 분야입니다. 전사체학은 DNA와 단백질 사이의 중간체인 RNA 전사의 양과 서열을 조사하여 유전자 발현과 조절에 대한 인사이트를 제공합니다. 이 분석은 세포 기능을 이해하고, 질병의 바이오마커를 식별하며, 잠재적인 치료 표적을 발견하는 데 매우 중요합니다. RNA 시퀀싱(RNA-Seq), 마이크로어레이, 정량적 PCR(qPCR)과 같은 기술은 일반적으로 다양한 조건이나 발달 단계에 걸쳐 RNA 수준을 측정하고 비교하기 위해 전사체학에서 사용됩니다. 이러한 방법을 통해 연구자들은 유전자 발현에 대한 포괄적인 프로파일을 구축하여 생물학적 과정과 질병 메커니즘의 복잡성을 밝힐 수 있습니다.

기술 발전으로 RNA 분석의 기능과 응용 분야가 크게 향상되었습니다. 특히 고처리량 시퀀싱 기술, RNA-Seq은 게놈 전체에 걸쳐 RNA 전사를 정확하고 포괄적으로 정량화할 수 있게 함으로써 전사체학에 혁명을 일으켰습니다. RNA-Seq은 기존 방법에 비해 더 상세하고 편견 없는 전사체 뷰를 제공하여 새로운 전사체, 스플라이스 변이체, 비코딩 RNA를 검출할 수 있게 해줍니다. 또한 단일 세포 RNA 시퀀싱(scRNA-Seq)은 단일 세포 수준에서 유전자 발현을 분석할 수 있는 혁신적인 기술로 부상하여 세포 이질성과 세포 과정의 역학을 전례 없는 분해능으로 밝혀내고 있습니다. 계산 도구와 생물정보학의 발전도 전사체학에서 중요한 역할을 하며 데이터 분석, 통합, 해석에 필요한 프레임워크를 제공함으로써 연구자들이 복잡한 데이터 세트에서 의미 있는 생물학적 인사이트를 도출할 수 있게 해줍니다.

개인 맞춤형 의료에 대한 수요 증가, 시퀀싱 기술의 발전, 만성 질환과 암의 유병률 증가 등 여러 요인에 의해 RNA 분석(전사체학) 시장의 성장이 주도되고 있습니다. 개인의 유전적 프로필에 따라 맞춤형 치료를 목표로 하는 개인 맞춤형 의학으로의 전환은 질병별 바이오마커와 치료 표적을 식별하기 위한 포괄적인 전사체 분석의 필요성을 촉진했습니다. 시퀀싱 기술의 지속적인 개선으로 정확도, 처리량, 비용 효율성이 높아지면서 전사체 연구에 대한 접근성이 향상되고 다양한 응용 분야에서 실현 가능해졌습니다.또한 만성 질환과 암의 발병률이 증가함에 따라 이러한 질환의 분자적 토대를 이해하는 데 대한 관심이 높아지면서 연구 및 임상 환경에서 전사체학이 채택되고 있습니다. 유전체학 연구를 위한 정부의 이니셔티브와 자금 지원, 학술 기관과 제약 회사 간의 협력도 시장 확대에 기여하고 있습니다. 그 결과, RNA 분석(전사체학) 분야는 생물학에 대한 이해를 높이고 의료 결과를 개선할 수 있는 지속적인 혁신과 애플리케이션을 통해 크게 성장할 것으로 전망됩니다.

부문

제품(시약 및 소모품, 장비, 서비스, 소프트웨어), 기술(중합 효소 연쇄반응, 시퀀싱, 마이크로어레이, RNA 간섭)

조사 대상 기업 예

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Analytik Jena AG
  • Ambry Genetics
  • Advanced Cell Diagnostics, Inc.
  • Bioneer Corporation
  • BioChain Institute, Inc.
  • Akoya Biosciences, Inc.
  • Acobiom
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • 10X Genomics
  • Biois Co Ltd
  • Bertin Technologies, Sas

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계의 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

HBR 25.02.25

Global RNA Analysis / Transcriptomics Market to Reach US$19.0 Billion by 2030

The global market for RNA Analysis / Transcriptomics estimated at US$8.9 Billion in the year 2024, is expected to reach US$19.0 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the RNA Analysis / Transcriptomics Instruments segment is estimated at 11.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.4% CAGR

The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global RNA Analysis / Transcriptomics Market - Key Trends & Drivers Summarized

RNA analysis, also known as transcriptomics, is a powerful and essential field in molecular biology that focuses on the study of RNA molecules within a cell or organism. Transcriptomics provides insights into gene expression and regulation by examining the quantity and sequences of RNA transcripts, which are the intermediates between DNA and proteins. This analysis is crucial for understanding cellular functions, identifying biomarkers for diseases, and discovering potential therapeutic targets. Techniques such as RNA sequencing (RNA-Seq), microarrays, and quantitative PCR (qPCR) are commonly used in transcriptomics to measure and compare RNA levels across different conditions or stages of development. These methods allow researchers to construct comprehensive profiles of gene expression, shedding light on the complexities of biological processes and disease mechanisms.

Technological advancements have significantly enhanced the capabilities and applications of RNA analysis. High-throughput sequencing technologies, particularly RNA-Seq, have revolutionized transcriptomics by enabling the precise and comprehensive quantification of RNA transcripts on a genome-wide scale. RNA-Seq provides a more detailed and unbiased view of the transcriptome compared to traditional methods, allowing for the detection of novel transcripts, splice variants, and non-coding RNAs. Additionally, single-cell RNA sequencing (scRNA-Seq) has emerged as a transformative technique that allows for the analysis of gene expression at the single-cell level, revealing cellular heterogeneity and the dynamics of cellular processes with unprecedented resolution. Advances in computational tools and bioinformatics have also played a crucial role in transcriptomics, providing the necessary frameworks for data analysis, integration, and interpretation, thus enabling researchers to derive meaningful biological insights from complex datasets.

The growth in the RNA analysis/transcriptomics market is driven by several factors, including the increasing demand for personalized medicine, advancements in sequencing technologies, and the rising prevalence of chronic diseases and cancer. The shift towards personalized medicine, which aims to tailor treatments based on an individual’s genetic profile, has spurred the need for comprehensive transcriptomic analysis to identify disease-specific biomarkers and therapeutic targets. Continuous improvements in sequencing technologies, resulting in higher accuracy, throughput, and cost-effectiveness, have made transcriptomic studies more accessible and feasible for a broader range of applications. Additionally, the rising incidence of chronic diseases and cancer has increased the focus on understanding the molecular underpinnings of these conditions, driving the adoption of transcriptomics in research and clinical settings. Government initiatives and funding for genomics research, along with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market's expansion. As a result, the RNA analysis/transcriptomics field is poised for significant growth, with ongoing innovations and applications promising to enhance our understanding of biology and improve healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the RNA Analysis / Transcriptomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents / Consumables, Instruments, Services, Software); Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference); Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 115 Featured) -

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Analytik Jena AG
  • Ambry Genetics
  • Advanced Cell Diagnostics, Inc.
  • Bioneer Corporation
  • BioChain Institute, Inc.
  • Akoya Biosciences, Inc.
  • Acobiom
  • ADS Biotec, Inc.
  • BGI Genomics Co Ltd.
  • 10X Genomics
  • Biois Co Ltd
  • Bertin Technologies, Sas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • RNA-Oriented Projects Set to Increase
    • Competition
    • RNA Analysis / Transcriptomics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • What is RNA-Seq Technology?
    • A Prelude to Transcriptomics Technologies
    • Global Market Prospects & Outlook
    • PCR Emerges as the Leading Technology
    • Drug Discovery Segment Poised to Lead the Global Market
    • North America Emerges as the Major Regional Market
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Trend Towards Personalized Medicine Fuels Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
    • Transcriptomics Assume Critical Importance amid Growing Prevalence of Chronic Diseases
    • World Diabetes and Population Statistics (2021, 2030 & 2045)
    • World Diabetes Prevalence (2000-2045)
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
    • Transcriptomics Applications in Disease and Diagnostic Profiling
    • Increasing PCR Applications in Biotechnology Sector
    • Progressive Growth of Omics Technologies: Opportunity for RNA Analysis/Transcriptomics Market
    • The Growing Role of Transcriptomics in Oncology
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • RNA Sequencing Critical for Cancer and Rare Diseases
    • Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiovascular Research
    • Bulk RNA Sequencing
    • Single-Cell Sequencing
    • Spatial Transcriptomics
    • Single-Cell RNA-seq Technologies Witness Steady Growth
    • The Evolution of scRNA-seq
    • Growth of Long-Read Transcriptome Sequencing
    • scRNA-seq for Autoimmune Inflammatory Rheumatic Diseases
    • SPLiTseq Beneficial for Understanding Cause of Disease
    • Gene Expression Microarray Technology Gains Ground
    • Microfluidics-based Droplet Technologies Demonstrate Growth
    • inDrops Approach Exhibits Growth
    • Spatial Transcriptomics Market Witnesses Significant Growth
    • Spatial Transcriptomic Data Analysis
    • Next Generation Sequencing Offers Increased Accuracy for Transcriptomics Activity
    • Single-cell NGS Witnesses Rapid Growth
    • RNA Sequencing Benefits Fuel Market Prospects
    • Blood Transcriptome Sequencing for Identifying Rare-Disease Genes
    • Rising Focus on Toxicogenomics: Potential for RNA Analysis/Transcriptomics Markets
    • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Technological Advancements & Innovations Fuel Market Growth
    • Sci-Plex - A New Technique to Profile Gene Expression within Single Cells
    • Introduction of Oxford Nanopore's Innovative Portable Sequencer for Sequencing Long Reads and RNA Molecules Improves Transcriptomic Analysis
    • RNA-Combine, a Toolkit for More Comprehensively Analyzing Transcriptome Data
    • Aging Demographics Present Opportunities for Transcriptomics Technologies
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Challenges Facing RNA/Transcriptomics Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RNA Analysis / Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents / Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Reagents / Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for RNA Interference by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for RNA Interference by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Toxicogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Toxicogenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Comparative Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Comparative Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World RNA Analysis / Transcriptomics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 59: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • CHINA
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • EUROPE
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for RNA Analysis / Transcriptomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 89: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 98: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 116: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for RNA Analysis / Transcriptomics by Product - Reagents / Consumables, Instruments, Services and Software Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Product - Percentage Breakdown of Value Revenues for Reagents / Consumables, Instruments, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for RNA Analysis / Transcriptomics by Technology - Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Technology - Percentage Breakdown of Value Revenues for Polymerase Chain Reaction, Sequencing, Microarrays and RNA Interference for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for RNA Analysis / Transcriptomics by Application - Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for RNA Analysis / Transcriptomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Toxicogenomics, Clinical Diagnostics and Comparative Transcriptomics for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제